Cargando…

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review

BACKGROUND: Neuroimaging-biomarkers of Mild Cognitive Impairment (MCI) allow an early diagnosis in preclinical stages of Alzheimer’s disease (AD). The goal in this paper was to review of biomarkers for Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD), with emphasis on neuroimaging biomar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Qingwei, D’Onofrio, Grazia, Sancarlo, Daniele, Bao, Zhijun, Greco, Antonio, Yu, Zhuowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869390/ https://www.ncbi.nlm.nih.gov/pubmed/27184250 http://dx.doi.org/10.1186/s12877-016-0281-7

Ejemplares similares

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty
por: Ruan, Qingwei, et al.
Publicado: (2016)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
por: D'Onofrio, Grazia, et al.
Publicado: (2016)

Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer’s Disease, Vascular Dementia, Psychobehavioral, and Functional Complications
por: Lauriola, Michele, et al.
Publicado: (2021)

Assistive Robots for Healthcare and Human–Robot Interaction
por: D’Onofrio, Grazia, et al.
Publicado: (2023)

Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Assessing Feasibility of Cognitive Impairment Testing Using Social Robotic Technology Augmented with Affective Computing and Emotional State Detection Systems
por: Russo, Sergio, et al.
Publicado: (2023)

Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences
por: Moore, Elizabeth E., et al.
Publicado: (2020)

Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
por: Ma, Cheng, et al.
Publicado: (2015)

Advances in Resting State Neuroimaging of Mild Cognitive Impairment
por: Lin, Li, et al.
Publicado: (2018)

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
por: Stage, Eddie, et al.
Publicado: (2021)

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
por: Harris, Paula, et al.
Publicado: (2015)

Neuroimaging Characteristics of Small-Vessel Disease in Older Adults with Normal Cognition, Mild Cognitive Impairment, and Alzheimer Disease
por: Mimenza-Alvarado, Alberto, et al.
Publicado: (2018)

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology
por: Hou, Jia-Hui, et al.
Publicado: (2022)

Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
por: Canevelli, Marco, et al.
Publicado: (2020)

Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer’s Disease Neuroimaging Initiative cohort
por: Gupta, Aditi, et al.
Publicado: (2020)

Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses
por: Ruan, Qingwei, et al.
Publicado: (2018)

Abnormal Cortical Networks in Mild Cognitive Impairment and Alzheimer's Disease
por: Yao, Zhijun, et al.
Publicado: (2010)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Neuroimaging and machine learning for studying the pathways from mild cognitive impairment to alzheimer’s disease: a systematic review
por: Ahmadzadeh, Maryam, et al.
Publicado: (2023)

Neurocognitive Disorders and Dehydration in Older Patients: Clinical Experience Supports the Hydromolecular Hypothesis of Dementia
por: Lauriola, Michele, et al.
Publicado: (2018)

Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype
por: Espinosa, Ana, et al.
Publicado: (2017)

Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment
por: Martínez-Torteya, Antonio, et al.
Publicado: (2015)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Acupuncture on mild cognitive impairment: A systematic review of neuroimaging studies
por: Yin, Zihan, et al.
Publicado: (2023)

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Neuroimaging criteria and cognitive performance in vascular mild cognitive impairment: A systematic review
por: Sudo, Felipe Kenji, et al.
Publicado: (2015)

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
por: Tan, Lin, et al.
Publicado: (2016)

The Clinical Use of Alzheimer’s Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer’s Disease Consortium Survey
por: Caprioglio, Camilla, et al.
Publicado: (2022)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
por: Samtani, Mahesh N, et al.
Publicado: (2014)

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
por: De Felice, Bruna, et al.
Publicado: (2020)

Nonlinear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease
por: Popescu, Sebastian G., et al.
Publicado: (2020)

Multimodality Neuroimaging in Mild Cognitive Impairment: A Cross-sectional Comparison Study
por: Sheelakumari, R., et al.
Publicado: (2018)

Neuroimaging and Psychometric Assessment of Mild Cognitive Impairment After Traumatic Brain Injury
por: Calvillo, Maria, et al.
Publicado: (2020)

Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment
por: Gullett, Joseph M., et al.
Publicado: (2021)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lk0q9jqcflbaicug4dnrtun2sk